We have previously shown nutritional intervention with
fish oil (n-3 PUFA) to reduce numerous complications associated with the
metabolic syndrome (MetS) in the JCR:LA-corpulent (cp) rat. In the present study, we sought to explore the potential role of
fish oil to prevent glomerulosclerosis in JCR:LA-cp rats via renal
eicosanoid metabolism and lipidomic analysis. Male lean and MetS JCR:LA-cp rats were fed a
lipid-balanced diet supplemented with
fish oil (5 or 10 % of total fat). After 16 weeks of feeding,
albuminuria was significantly reduced in MetS rats supplemented with 5 or 10 %
fish oil ( - 53 and - 70 %, respectively, compared with the untreated MetS rats). The 5 %
fish oil diet resulted in markedly lower glomerulosclerosis ( - 43 %) in MetS rats and to a lesser extent in those supplemented with 10 %
fish oil. Interestingly, untreated MetS rats had higher levels of 11- and 12-hydroxyeicosatetraenoic
acids (
HETE) v. lean rats. Dietary
fish oil reduced these levels, as well as other (5-, 9- and 15-)
HETE. Whilst genotype did not alter
prostanoid levels,
fish oil reduced endogenous renal levels of 6-keto PGF1α (PGI2 metabolite),
thromboxane B2 (TxB2), PGF2α and
PGD2 by approximately 60 % in rats fed 10 %
fish oil, and TxB2 ( - 50 %) and PGF2α ( - 41 %) in rats fed 5 %
fish oil. In conclusion, dietary
fish oil prevented glomerular damage in MetS rats and mitigated the elevation in renal
HETE levels. These results suggest a potential role for dietary
fish oil to improve dysfunctional renal
eicosanoid metabolism associated with kidney damage during conditions of the MetS.